Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges

Shahar Taiber, Karen B. Avraham

Research output: Contribution to journalReview articlepeer-review


More than 15 years have passed since the official completion of the Human Genome Project. Predominantly due to this project, over one hundred genes have now been linked to hearing loss. Although major advancements have been made in the understanding of underlying pathologies in deafness as a consequence of these gene discoveries, biological treatments for these conditions are still not available and current treatments rely on amplification or prosthetics. A promising approach for developing treatments for genetic hearing loss is the most simplistic one, that of gene therapy. Gene therapy would intuitively be ideal for these conditions since it is directed at the very source of the problem. Recent achievements in this field in laboratory models spike hope and optimism among scientists, patients, and industry, and suggest that this approach can mature into clinical trials in the coming years. Here we review the existing literature and discuss the different aspects of developing gene therapy for genetic hearing loss.

Original languageEnglish
Article number134527
JournalNeuroscience Letters
StatePublished - 20 Nov 2019


  • Cochlea
  • Deafness
  • Gene editing
  • Gene therapy
  • Hair cells
  • Inner ear


Dive into the research topics of 'Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges'. Together they form a unique fingerprint.

Cite this